Andreas Daniel Meid (Andreas D Meid, Andreas Meid)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 27

Top Topics

Atrial Fibrillation

Machine Learning

Health Insurance

Top Venues

British journal of clinical pharmacology

Pharmacology research & perspectives

This page only lists publications with an associated author ORCID identifier.

Publications

Janina A Bittmann, Camilo Scherkl, Andreas Daniel Meid, Walter Emil Haefeli, Hanna Marita Seidling
Event Analysis for Automated Estimation of Absent and Persistent Medication Alerts: Novel Methodology. JMIR medical informatics 12 (2024)
Andreas Daniel Meid, Camilo Scherkl, Michael Metzner, David Czock, Hanna Marita Seidling
Real-World Application of a Quantitative Systems Pharmacology (QSP) Model to Predict Potassium Concentrations from Electronic Health Records: A Pilot Case towards Prescribing Monitoring of Spironolactone. Pharmaceuticals (Basel, Switzerland) 17 (8) (2024)
Rebecca T Levinson, Cinara Paul, Andreas Daniel Meid, Jobst-Hendrik Schultz, Beate Wild
Identifying Predictors of Heart Failure Readmission in Patients From a Statutory Health Insurance Database: Retrospective Machine Learning Study. JMIR cardio 8 (2024)
Rebecca T Levinson, Cinara Paul, Andreas Daniel Meid, Jobst-Hendrik Schultz, Beate Wild
Identifying Predictors of Heart Failure Readmission in Patients From a Statutory Health Insurance Database: Retrospective Machine Learning Study. JMIR cardio 8 (2024)
Rebecca T Levinson, Cinara Paul, Andreas Daniel Meid, Jobst-Hendrik Schultz, Beate Wild
Identifying Predictors of Heart Failure Readmission in Patients From a Statutory Health Insurance Database: Retrospective Machine Learning Study. JMIR cardio 8 (2024)
Camilo Scherkl, Andreas Daniel Meid, Sven E Cuntz, Laura Classen, Johanna Weiss, David Czock, Walter Emil Haefeli
Coadministration of fluconazole to boost subtherapeutic sirolimus concentrations: A case report. Pharmacology research & perspectives 12 (3) (2024)
Andreas Daniel Meid, Camilo Scherkl, Michael Metzner, David Czock, Hanna Marita Seidling
Real-World Application of a Quantitative Systems Pharmacology (QSP) Model to Predict Potassium Concentrations from Electronic Health Records: A Pilot Case towards Prescribing Monitoring of Spironolactone. Pharmaceuticals (Basel, Switzerland) 17 (8) (2024)
Janina A Bittmann, Camilo Scherkl, Andreas Daniel Meid, Walter Emil Haefeli, Hanna Marita Seidling
Event Analysis for Automated Estimation of Absent and Persistent Medication Alerts: Novel Methodology. JMIR medical informatics 12 (2024)
Camilo Scherkl, Andreas Daniel Meid, Sven E Cuntz, Laura Classen, Johanna Weiss, David Czock, Walter Emil Haefeli
Coadministration of fluconazole to boost subtherapeutic sirolimus concentrations: A case report. Pharmacology research & perspectives 12 (3) (2024)
Camilo Scherkl, Andreas Daniel Meid, Sven E Cuntz, Laura Classen, Johanna Weiss, David Czock, Walter Emil Haefeli
Coadministration of fluconazole to boost subtherapeutic sirolimus concentrations: A case report. Pharmacology research & perspectives 12 (3) (2024)
Janina A Bittmann, Camilo Scherkl, Andreas Daniel Meid, Walter Emil Haefeli, Hanna Marita Seidling
Event Analysis for Automated Estimation of Absent and Persistent Medication Alerts: Novel Methodology. JMIR medical informatics 12 (2024)
Camilo Scherkl, Andreas Daniel Meid, Sven E Cuntz, Laura Classen, Johanna Weiss, David Czock, Walter Emil Haefeli
Coadministration of fluconazole to boost subtherapeutic sirolimus concentrations: A case report. Pharmacology research & perspectives 12 (3) (2024)
Amin Muhareb, Antje Blank, Andreas Daniel Meid, Kathrin I Foerster, Felicitas Stoll, Juergen Burhenne, Walter Emil Haefeli, Gerd Mikus
CYP3A and CYP2C19 Activity Determined by Microdosed Probe Drugs Accurately Predict Voriconazole Clearance in Healthy Adults. Clinical pharmacokinetics (2023)
Evelyn Krohmer, Brit Silja Rohr, Felicitas Stoll, Katja S Gümüs, Mariano Bergamino, Gerd Mikus, Max Sauter, Juergen Burhenne, Johanna Weiss, Andreas Daniel Meid, David Czock, Antje Blank, Walter Emil Haefeli
Influence of a Short Course of Ritonavir Used as Booster in Antiviral Therapies Against SARS-CoV-2 on the Exposure of Atorvastatin and Rosuvastatin. Cardiovascular drugs and therapy (2023)
Dirk Theile, Julie Nilles, Andreas Daniel Meid
Physiology-based pharmacokinetic modelling and experimental data suggest that rifabutin alters dolutegravir kinetics by both P-glycoprotein induction and concurrent inhibition. British journal of clinical pharmacology (2023)
Andreas Daniel Meid, Alexander Gerharz, Andreas Groll
Machine learning for tumor growth inhibition: Interpretable predictive models for transparency and reproducibility. CPT: pharmacometrics & systems pharmacology 11 (3) (2022)
Benedict Morath, Andreas Daniel Meid, Marcin Zaradzki, Carolin Geßele, Stefanie Nüse, Ute Chiriac, Torsten Hoppe-Tichy, Matthias Karck, Jasmin Soethoff
Analysing and improving preoperative medication management in cardiac surgery. British journal of clinical pharmacology (2022)
Lucas Wirbka, Walter Emil Haefeli, Andreas Daniel Meid, null null
Estimated Thresholds of Minimum Necessary Adherence for Effective Treatment with Direct Oral Anticoagulants - A Retrospective Cohort Study in Health Insurance Claims Data. Patient preference and adherence 15 (2021)
Carmen Ruff, Alexander Gerharz, Andreas Groll, Felicitas Stoll, Lucas Wirbka, Walter E Haefeli, Andreas Daniel Meid
Disease-dependent variations in the timing and causes of readmissions in Germany: A claims data analysis for six different conditions. PloS one 16 (4) (2021)
Andreas Daniel Meid, Lucas Wirbka, null null, Andreas Groll, Walter Emil Haefeli
Can Machine Learning from Real-World Data Support Drug Treatment Decisions? A Prediction Modeling Case for Direct Oral Anticoagulants. Medical decision making : an international journal of the Society for Medical Decision Making 42 (5) (2021)
Andreas Daniel Meid
Teaching reproducible research for medical students and postgraduate pharmaceutical scientists. BMC research notes 14 (1) (2021)
Hans-Helmut König, Katrin C Reber, Ivonne Lindlbauer, Kilian Rapp, Gisela Büchele, Jochen Klenk, Andreas Daniel Meid, Clemens Becker, Hans-Helmut König
Osteoporotic hip fracture prediction from risk factors available in administrative claims data - A machine learning approach. PloS one 15 (5) (2020)
Andreas Daniel Meid, Carmen Ruff, Lucas Wirbka, Felicitas Stoll, Hanna M Seidling, Andreas Groll, Walter Emil Haefeli
Using the Causal Inference Framework to Support Individualized Drug Treatment Decisions Based on Observational Healthcare Data. Clinical epidemiology 12 (2020)
Lucas Wirbka, Walter E Haefeli, Andreas Daniel Meid
A framework to build similarity-based cohorts for personalized treatment advice - a standardized, but flexible workflow with the R package SimBaCo. PloS one 15 (5) (2020)
Andreas Daniel Meid, Walter E Haefeli
Refining estimates of prescription durations by using observed covariates in pharmacoepidemiologic databases: Necessary refinements to stimulate alternative approaches. Pharmacoepidemiology and drug safety 26 (9) (2019)
Andrea Huppertz, Lars Werntz, Andreas Daniel Meid, Kathrin I Foerster, Juergen Burhenne, David Czock, Gerd Mikus, Walter Emil Haefeli
Rivaroxaban and macitentan can be coadministered without dose adjustment but the combination of rivaroxaban and St John's wort should be avoided. British journal of clinical pharmacology 84 (12) (2018)
Andreas Daniel Meid, Sarah Mächler, Walter E Haefeli, Gerd Mikus
Real-world complexity of atrial fibrillation treatment with oral anticoagulants: design and interpretation of pharmacoepidemiological studies. British journal of clinical pharmacology 83 (10) (2017)